{
  "main_header": {
    "sid": 1117573,
    "name": "Porton Pharma Solutions Ltd.",
    "stock_name": "Porton Pharma Solutions Ltd.",
    "full_name": "Porton Pharma Solutions Ltd.",
    "name_url": "stocks-analysis/porton-pharma-solutions",
    "exchange": 46,
    "exchangecode": "SHE",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "23.13",
    "chg": -0.06,
    "chgp": "-0.26%",
    "dir": -1,
    "prev_price": "23.19",
    "mcapval": "12,483.73",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2310,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100001S57",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "9.82 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/porton-pharma-solutions-1117573-46&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Porton Pharma Solutions Ltd. Faces Challenges Amidst Mixed Financial Results",
        "link": "https://www.marketsmojo.com/news/mojo-premium/porton-pharma-solutions-ltd-joins-reliable-performers-strategy-amidst-financial-challenges-3526133",
        "imagepath": "",
        "date": "2025-09-17 17:14:59",
        "description": "<p><strong>Porton Pharma Solutions Ltd.</strong>, a prominent player in the Pharmaceuticals & Biotechnology sector, has reported a challenging financial performance for the quarter ending March 2025. Despite a notable increase in net sales, the company has faced significant losses, raising concerns among investors.</p>\n\n<p>For the nine-month period, <strong>Porton Pharma Solutions Ltd.</strong> recorded net sales of CNY 2,442.54 MM, reflecting a growth of 23.04% compared to the previous year. This increase in sales indicates a positive trend in revenue generation, which is crucial for the company's overall performance.</p>\n\n<p>However, the financial results also revealed troubling figures in terms of profitability. The pre-tax profit for the quarter was reported at CNY -0.17 MM, marking a significant loss. Additionally, the net profit for the same period stood at CNY -4.28 MM, indicating that the company is..."
      }
    ],
    "total": 1,
    "sid": "1117573",
    "stock_news_url": "https://www.marketsmojo.com/news/porton-pharma-solutions-1117573"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Porton Pharma Solutions Ltd. Faces Challenges Amidst Mixed Financial Results

2025-09-17 17:14:59

Porton Pharma Solutions Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has reported a challenging financial performance for the quarter ending March 2025. Despite a notable increase in net sales, the company has faced significant losses, raising concerns among investors.

For the nine-month period, Porton Pharma Solutions Ltd. recorded net sales of CNY 2,442.54 MM, reflecting a growth of 23.04% compared to the previous year. This increase in sales indicates a positive trend in revenue generation, which is crucial for the company's overall performance.

However, the financial results also revealed troubling figures in terms of profitability. The pre-tax profit for the quarter was reported at CNY -0.17 MM, marking a significant loss. Additionally, the net profit for the same period stood at CNY -4.28 MM, indicating that the company is...

Read More

View All News